• Bio Essence Corp. posted net income of $205,373 for the three months ended March 31, 2026, swinging from a net loss of $205,752 a year earlier.
• Revenue climbed to $500,537 from $22,189, driven by OEM services revenue of $500,537 on higher order volume, including large orders from one new major customer.
• Operating income was $215,795, reversing from an operating loss of $205,092, while general and administrative expenses fell 54.3% to $102,878.
• Cash and equivalents totaled $36,177 at March 31, 2026, with a working capital deficit of $1.37 million and a current ratio of 0.37:1.
• Accrued about $1.5 million under lease liabilities tied to a lawsuit over early vacation of Irvine facility, while a separate Statement of Work claim was not accrued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Essence Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-057529), on May 15, 2026, and is solely responsible for the information contained therein.